Related Experiment Video
Updated: Sep 28, 2026

Mouse Kidney Transplantation: Models of Allograft Rejection
Published on: October 11, 2014
Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft
1Division of Renal Disease, Brown University School of Medicine, Rhode Island and Miriam Hospitals, 593 Eddy Street, Providence, RI 02903, USA.
Abstract:
Parvovirus B19 is a nonenveloped single-stranded DNA virus that commonly causes a benign childhood infection typically manifesting as a "slapped-cheek" rash. In immunodeficient hosts, this infection can cause persistent anemia and occasionally pancytopenia. Recently, direct renal involvement has been reported in renal transplant recipients leading to various forms of glomerulopathy and allograft dysfunction. Most cases are primary infections and are donor transmitted through the transplanted organ. Clinical and virological response to intravenous immunoglobulin (Ig) is usually excellent. We describe a case of donor-transmitted parvovirus infection in a 23-year-old male who received his first cadaver renal transplant. The patient had an uncomplicated postoperative course with immediate graft function. Eight weeks after transplantation, he presented with fever, polyarthralgia, pancytopenia, and allograft dysfunction. Serological studies revealed elevated IgM titers against parvovirus B19. A renal biopsy was performed, which showed no evidence of acute rejection but with moderate degree of tubular damage. Parvovirus B19 viral DNA was detected in the renal tissue via polymerase chain reaction (PCR). The patient received a 10-day course of intravenous Ig (400 mg/kg/day) with excellent response. His blood count normalized and the allograft improved to baseline function. The incidence of parvovirus infection in renal transplant patients is probably underestimated, because patients are not routinely screened for it and anemia and/or pancytopenia in these patients are often ascribed to immunosuppressive drugs. Because this infection is treatable, we conclude that parvovirus B19 infection should be actively considered in transplant patients presenting with pancytopenia and allograft dysfunction.
Insights
Donor-transmitted parvovirus B19 infection can cause serious complications in renal transplant recipients, including pancytopenia and allograft dysfunction. Prompt treatment with intravenous immunoglobulin (Ig) leads to excellent recovery, highlighting the need for increased vigilance.
Area of Science:
- Virology
- Nephrology
- Immunology
Background:
- Parvovirus B19, a nonenveloped single-stranded DNA virus, typically causes mild childhood illness but can lead to persistent anemia and pancytopenia in immunocompromised individuals.
- Renal involvement, including glomerulopathy and allograft dysfunction, has been increasingly reported in renal transplant recipients, often due to donor transmission.
Observation:
- A 23-year-old male renal transplant recipient developed fever, polyarthralgia, pancytopenia, and allograft dysfunction eight weeks post-transplant.
- Serological tests showed elevated parvovirus B19 IgM titers, and renal biopsy revealed tubular damage without rejection. Parvovirus B19 DNA was detected in renal tissue via PCR.
Findings:
- The patient received a 10-day course of intravenous immunoglobulin (Ig) at 400 mg/kg/day.
- Following treatment, the patient experienced normalization of blood counts and improvement in allograft function.
Implications:
- Parvovirus B19 infection in renal transplant patients may be underdiagnosed, as symptoms can be mistaken for immunosuppressive drug side effects.
- Active screening for parvovirus B19 is recommended in transplant patients presenting with pancytopenia and allograft dysfunction due to its treatable nature.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cytomegalovirus Disease